{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T19:51:56Z","timestamp":1788983516206,"version":"build-2803163510"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,11,21]],"date-time":"2020-11-21T00:00:00Z","timestamp":1605916800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,21]],"date-time":"2020-11-21T00:00:00Z","timestamp":1605916800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81671301"],"award-info":[{"award-number":["81671301"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81701279"],"award-info":[{"award-number":["81701279"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s10072-020-04891-8","type":"journal-article","created":{"date-parts":[[2020,11,21]],"date-time":"2020-11-21T16:02:36Z","timestamp":1605974556000},"page":"521-530","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Seizures in steroid-responsive encephalopathy"],"prefix":"10.1007","volume":"42","author":[{"given":"Xin","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aolei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1494-0223","authenticated-orcid":false,"given":"Xuefeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,21]]},"reference":[{"key":"4891_CR1","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S0140-6736(66)92876-5","volume":"2","author":"L Brain","year":"1966","unstructured":"Brain L, Jellinek EH, Ball K (1966) Hashimoto's disease and encephalopathy. Lancet 2:512\u2013514","journal-title":"Lancet"},{"key":"4891_CR2","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/brain\/91.3.481","volume":"91","author":"JA Corsellis","year":"1968","unstructured":"Corsellis JA, Goldberg GJ, Norton AR (1968) \"Limbic encephalitis\" and its association with carcinoma. Brain 91:481\u2013496","journal-title":"Brain"},{"key":"4891_CR3","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jamaneurol.2014.188","volume":"71","author":"MS Ong","year":"2014","unstructured":"Ong MS, Kohane IS, Cai T, Gorman MP, Mandl KD (2014) Population-level evidence for an autoimmune etiology of epilepsy. JAMA Neurol 71:569\u2013574","journal-title":"JAMA Neurol"},{"key":"4891_CR4","doi-asserted-by":"crossref","unstructured":"(1999) The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 42:599\u2013608","DOI":"10.1002\/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F"},{"key":"4891_CR5","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1055\/s-2007-1024428","volume":"124","author":"V Arbusow","year":"1999","unstructured":"Arbusow V, Samtleben W (1999) Neurologic complications in ANCA-associated vasculitis. Dtsch Med Wochenschr 124:835\u2013841","journal-title":"Dtsch Med Wochenschr"},{"key":"4891_CR6","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1552-6569.2001.tb00012.x","volume":"11","author":"P Thajeb","year":"2001","unstructured":"Thajeb P, Tsai JJ (2001) Cerebral and oculorhinal manifestations of a limited form of Wegener's granulomatosis with c-ANCA-associated vasculitis. J Neuroimaging 11:59\u201363","journal-title":"J Neuroimaging"},{"key":"4891_CR7","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1126\/science.102.2659.618","volume":"102","author":"J Casals","year":"1945","unstructured":"Casals J (1945) Heated, avirulent antigens for complement-fixation tests with certain encephalitis viruses. Science 102:618\u2013619","journal-title":"Science"},{"issue":"Suppl 6","key":"4891_CR8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1528-1167.2008.01751.x","volume":"49","author":"UK Misra","year":"2008","unstructured":"Misra UK, Tan CT, Kalita J (2008) Viral encephalitis and epilepsy. Epilepsia 49(Suppl 6):13\u201318","journal-title":"Epilepsia"},{"key":"4891_CR9","first-page":"1145","volume":"18","author":"J Kawafuchi","year":"1966","unstructured":"Kawafuchi J, Kano T, Sato K (1966) 2 cases of primary sarcoma of the brain. No Shinkei Brain nerve 18:1145\u20131150","journal-title":"No Shinkei Brain nerve"},{"key":"4891_CR10","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1001\/archneur.60.2.164","volume":"60","author":"JY Chong","year":"2003","unstructured":"Chong JY, Rowland LP, Utiger RD (2003) Hashimoto encephalopathy: syndrome or myth? Arch Neurol 60:164\u2013171","journal-title":"Arch Neurol"},{"key":"4891_CR11","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.autrev.2016.09.008","volume":"15","author":"C Laurent","year":"2016","unstructured":"Laurent C, Capron J, Quillerou B, Thomas G, Alamowitch S, Fain O, Mekinian A (2016) Steroid-responsive encephalopathy associated with autoimmune thyroiditis (SREAT): characteristics, treatment and outcome in 251 cases from the literature. Autoimmun Rev 15:1129\u20131133","journal-title":"Autoimmun Rev"},{"key":"4891_CR12","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/archneur.63.2.197","volume":"63","author":"P Castillo","year":"2006","unstructured":"Castillo P, Woodruff B, Caselli R, Vernino S, Lucchinetti C, Swanson J, Noseworthy J, Aksamit A, Carter J, Sirven J, Hunder G, Fatourechi V, Mokri B, Drubach D, Pittock S, Lennon V, Boeve B (2006) Steroid-responsive encephalopathy associated with autoimmune thyroiditis. Arch Neurol 63:197\u2013202","journal-title":"Arch Neurol"},{"key":"4891_CR13","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1212\/WNL.41.2_Part_1.228","volume":"41","author":"PJ Shaw","year":"1991","unstructured":"Shaw PJ, Walls TJ, Newman PK, Cleland PG, Cartlidge NE (1991) Hashimoto's encephalopathy: a steroid-responsive disorder associated with high anti-thyroid antibody titers--report of 5 cases. Neurology 41:228\u2013233","journal-title":"Neurology"},{"key":"4891_CR14","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1684\/epd.2017.0904","volume":"19","author":"C Varrasi","year":"2017","unstructured":"Varrasi C, Vecchio D, Magistrelli L, Strigaro G, Tassi L, Cantello R (2017) Auditory seizures in autoimmune epilepsy: a case with anti-thyroid antibodies. Epileptic Disord 19:99\u2013103","journal-title":"Epileptic Disord"},{"key":"4891_CR15","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3345\/kjp.2012.55.3.111","volume":"55","author":"MJ Lee","year":"2012","unstructured":"Lee MJ, Lee HS, Hwang JS, Jung DE (2012) A case of Hashimoto's encephalopathy presenting with seizures and psychosis. Korean J Pediatr 55:111\u2013113","journal-title":"Korean J Pediatr"},{"key":"4891_CR16","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3109\/00207454.2013.836706","volume":"124","author":"G Gul Mert","year":"2014","unstructured":"Gul Mert G, Horoz OO, Herguner MO, Incecik F, Yildizdas RD, Onenli Mungan N, Yuksel B, Altunbasak S (2014) Hashimoto's encephalopathy: four cases and review of literature. Int J Neurosci 124:302\u2013306","journal-title":"Int J Neurosci"},{"key":"4891_CR17","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1176\/jnp.23.4.jnp384","volume":"23","author":"NC de Holanda","year":"2011","unstructured":"de Holanda NC, de Lima DD, Cavalcanti TB, Lucena CS, Bandeira F (2011) Hashimoto's encephalopathy: systematic review of the literature and an additional case. J Neuropsychiatr Clin Neurosci 23:384\u2013390","journal-title":"J Neuropsychiatr Clin Neurosci"},{"key":"4891_CR18","first-page":"438","volume":"10","author":"A Arain","year":"2001","unstructured":"Arain A, Abou-Khalil B, Moses H (2001) Hashimoto's encephalopathy: documentation of mesial temporal seizure origin by ictal EEG. Seizure 10:438\u2013441","journal-title":"Seizure"},{"key":"4891_CR19","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jns.2013.05.009","volume":"331","author":"I Olmez","year":"2013","unstructured":"Olmez I, Moses H, Sriram S, Kirshner H, Lagrange AH, Pawate S (2013) Diagnostic and therapeutic aspects of Hashimoto's encephalopathy. J Neurol Sci 331:67\u201371","journal-title":"J Neurol Sci"},{"key":"4891_CR20","doi-asserted-by":"crossref","first-page":"102339","DOI":"10.1016\/j.jaut.2019.102339","volume":"104","author":"H Alexopoulos","year":"2019","unstructured":"Alexopoulos H, Dalakas MC (2019) The immunobiology of autoimmune encephalitides. J Autoimmun 104:102339","journal-title":"J Autoimmun"},{"key":"4891_CR21","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.yebeh.2005.11.005","volume":"8","author":"E Ferlazzo","year":"2006","unstructured":"Ferlazzo E, Raffaele M, Mazzu I, Pisani F (2006) Recurrent status epilepticus as the main feature of Hashimoto's encephalopathy. Epilepsy Behavior 8:328\u2013330","journal-title":"Epilepsy Behavior"},{"key":"4891_CR22","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3389\/fneur.2019.00440","volume":"10","author":"J Li","year":"2019","unstructured":"Li J, Li F (2019) Hashimoto's encephalopathy and seizure disorders. Front Neurol 10:440","journal-title":"Front Neurol"},{"key":"4891_CR23","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jns.2014.11.007","volume":"348","author":"LC Wong","year":"2015","unstructured":"Wong LC, Freeburg JD, Montouris GD, Hohler AD (2015) Two patients with Hashimoto's encephalopathy and uncontrolled diabetes successfully treated with levetiracetam. J Neurol Sci 348:251\u2013252","journal-title":"J Neurol Sci"},{"key":"4891_CR24","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.eplepsyres.2011.04.006","volume":"95","author":"LA Rudzinski","year":"2011","unstructured":"Rudzinski LA, Pittock SJ, McKeon A, Lennon VA, Britton JW (2011) Extratemporal EEG and MRI findings in ANNA-1 (anti-Hu) encephalitis. Epilepsy Res 95:255\u2013262","journal-title":"Epilepsy Res"},{"issue":"Pt 7","key":"4891_CR25","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/brain\/123.7.1481","volume":"123","author":"SH Gultekin","year":"2000","unstructured":"Gultekin SH, Rosenfeld MR, Voltz R, Eichen J, Posner JB, Dalmau J (2000) Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain 123(Pt 7):1481\u20131494","journal-title":"Brain"},{"key":"4891_CR26","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/1752-1947-2-270","volume":"2","author":"V Voutsas","year":"2008","unstructured":"Voutsas V, Mylonaki E, Gymnopoulos K, Kapetangiorgis A, Grigoriadis C, Papaemanuell S, Vafiadis E, Christaki P (2008) Paraneoplastic limbic encephalitis as a cause of new onset of seizures in a patient with non-small cell lung carcinoma: a case report. J Med Case Rep 2:270","journal-title":"J Med Case Rep"},{"key":"4891_CR27","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s13311-019-00750-3","volume":"16","author":"KS Husari","year":"2019","unstructured":"Husari KS, Dubey D (2019) Autoimmune Epilepsy. Neurotherapeutics 16:685\u2013702","journal-title":"Neurotherapeutics"},{"key":"4891_CR28","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1212\/WNL.0b013e3182a9585f","volume":"81","author":"R Hoftberger","year":"2013","unstructured":"Hoftberger R, Titulaer MJ, Sabater L, Dome B, Rozsas A, Hegedus B, Hoda MA, Laszlo V, Ankersmit HJ, Harms L, Boyero S, de Felipe A, Saiz A, Dalmau J, Graus F (2013) Encephalitis and GABAB receptor antibodies: novel findings in a new case series of 20 patients. Neurology 81:1500\u20131506","journal-title":"Neurology"},{"key":"4891_CR29","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1136\/jnnp-2014-308814","volume":"86","author":"M Dogan Onugoren","year":"2015","unstructured":"Dogan Onugoren M, Deuretzbacher D, Haensch CA, Hagedorn HJ, Halve S, Isenmann S, Kramme C, Lohner H, Melzer N, Monotti R, Presslauer S, Schabitz WR, Steffanoni S, Stoeck K, Strittmatter M, Stogbauer F, Trinka E, von Oertzen TJ, Wiendl H, Woermann FG, Bien CG (2015) Limbic encephalitis due to GABAB and AMPA receptor antibodies: a case series. J Neurol Neurosurg Psychiatry 86:965\u2013972","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4891_CR30","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3892\/etm.2020.8684","volume":"20","author":"XH Zhao","year":"2020","unstructured":"Zhao XH, Yang X, Liu XW, Wang SJ (2020) Clinical features and outcomes of Chinese patients with anti-gamma-aminobutyric acid B receptor encephalitis. Exp Ther Med 20:617\u2013622","journal-title":"Exp Ther Med"},{"key":"4891_CR31","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/ana.21917","volume":"67","author":"MP Malter","year":"2010","unstructured":"Malter MP, Helmstaedter C, Urbach H, Vincent A, Bien CG (2010) Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis. Ann Neurol 67:470\u2013478","journal-title":"Ann Neurol"},{"key":"4891_CR32","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/jca.21342","volume":"30","author":"MS Farooqi","year":"2015","unstructured":"Farooqi MS, Lai Y, Lancaster E, Schmitt SE, Sachais BS (2015) Therapeutic plasma exchange and immunosuppressive therapy in a patient with anti-GAD antibody-related epilepsy: quantification of the antibody response. J Clin Apher 30:8\u201314","journal-title":"J Clin Apher"},{"key":"4891_CR33","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1136\/jnnp.2009.178293","volume":"81","author":"SH Wong","year":"2010","unstructured":"Wong SH, Saunders MD, Larner AJ, Das K, Hart IK (2010) An effective immunotherapy regimen for VGKC antibody-positive limbic encephalitis. J Neurol Neurosurg Psychiatry 81:1167\u20131169","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4891_CR34","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1111\/ene.12186","volume":"20","author":"C Frisch","year":"2013","unstructured":"Frisch C, Malter MP, Elger CE, Helmstaedter C (2013) Neuropsychological course of voltage-gated potassium channel and glutamic acid decarboxylase antibody related limbic encephalitis. Eur J Neurol 20:1297\u20131304","journal-title":"Eur J Neurol"},{"key":"4891_CR35","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1212\/01.WNL.0000122648.19196.02","volume":"62","author":"MJ Thieben","year":"2004","unstructured":"Thieben MJ, Lennon VA, Boeve BF, Aksamit AJ, Keegan M, Vernino S (2004) Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody. Neurology 62:1177\u20131182","journal-title":"Neurology"},{"key":"4891_CR36","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/brain\/awh077","volume":"127","author":"A Vincent","year":"2004","unstructured":"Vincent A, Buckley C, Schott JM, Baker I, Dewar BK, Detert N, Clover L, Parkinson A, Bien CG, Omer S (2004) Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 127:701\u2013712","journal-title":"Brain"},{"key":"4891_CR37","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3174\/ajnr.A3633","volume":"35","author":"AL Kotsenas","year":"2014","unstructured":"Kotsenas AL, Watson RE, Pittock SJ, Britton JW, Hoye SL, Quek AM, Shin C, Klein CJ (2014) MRI findings in autoimmune voltage-gated potassium channel complex encephalitis with seizures: one potential etiology for mesial temporal sclerosis. AJNR Am J Neuroradiol 35:84\u201389","journal-title":"AJNR Am J Neuroradiol"},{"key":"4891_CR38","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1176\/appi.neuropsych.13070158","volume":"27","author":"W Wang","year":"2015","unstructured":"Wang W, Zheng HB, Xiao J, Chen L, Zhou D (2015) Levetiracetam effect on adult-onset temporal lobe epilepsy with positive voltage-gated potassium channel antibody. J Neuropsychiatr Clin Neurosci 27:e100\u2013e106","journal-title":"J Neuropsychiatr Clin Neurosci"},{"key":"4891_CR39","doi-asserted-by":"crossref","first-page":"18161","DOI":"10.1523\/JNEUROSCI.3506-13.2013","volume":"33","author":"T Ohkawa","year":"2013","unstructured":"Ohkawa T, Fukata Y, Yamasaki M, Miyazaki T, Yokoi N, Takashima H, Watanabe M, Watanabe O, Fukata M (2013) Autoantibodies to epilepsy-related LGI1 in limbic encephalitis neutralize LGI1-ADAM22 interaction and reduce synaptic AMPA receptors. J Neurosci 33:18161\u201318174","journal-title":"J Neurosci"},{"key":"4891_CR40","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S1474-4422(10)70137-X","volume":"9","author":"M Lai","year":"2010","unstructured":"Lai M, Huijbers MG, Lancaster E, Graus F, Bataller L, Balice-Gordon R, Cowell JK, Dalmau J (2010) Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol 9:776\u2013785","journal-title":"Lancet Neurol"},{"key":"4891_CR41","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.seizure.2013.06.004","volume":"22","author":"JB Lilleker","year":"2013","unstructured":"Lilleker JB, Jones MS, Mohanraj R (2013) VGKC complex antibodies in epilepsy: diagnostic yield and therapeutic implications. Seizure 22:776\u2013779","journal-title":"Seizure"},{"key":"4891_CR42","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.seizure.2014.04.013","volume":"23","author":"R Rocamora","year":"2014","unstructured":"Rocamora R, Becerra JL, Fossas P, Gomez M, Vivanco-Hidalgo RM, Mauri JA, Molins A (2014) Pilomotor seizures: an autonomic semiology of limbic encephalitis? Seizure 23:670\u2013673","journal-title":"Seizure"},{"key":"4891_CR43","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/ene.13324","volume":"24","author":"M Celicanin","year":"2017","unstructured":"Celicanin M, Blaabjerg M, Maersk-Moller C, Beniczky S, Marner L, Thomsen C, Bach FW, Kondziella D, Andersen H, Somnier F, Illes Z, Pinborg LH (2017) Autoimmune encephalitis associated with voltage-gated potassium channels-complex and leucine-rich glioma-inactivated 1 antibodies - a national cohort study. Eur J Neurol 24:999\u20131005","journal-title":"Eur J Neurol"},{"key":"4891_CR44","doi-asserted-by":"crossref","first-page":"577268","DOI":"10.1016\/j.jneuroim.2020.577268","volume":"345","author":"R Uribe-San-Martin","year":"2020","unstructured":"Uribe-San-Martin R, Ciampi E, Santibanez R, Irani SR, Marquez A, Cruz JP, Soler B, Miranda MC, Henriquez M, Carcamo C (2020) LGI1-antibody associated epilepsy successfully treated in the outpatient setting. J Neuroimmunol 345:577268","journal-title":"J Neuroimmunol"},{"key":"4891_CR45","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1177\/0961203306070990","volume":"15","author":"HH Yu","year":"2006","unstructured":"Yu HH, Lee JH, Wang LC, Yang YH, Chiang BL (2006) Neuropsychiatric manifestations in pediatric systemic lupus erythematosus: a 20-year study. Lupus 15:651\u2013657","journal-title":"Lupus"},{"key":"4891_CR46","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1159\/000121423","volume":"59","author":"A Gonzalez-Duarte","year":"2008","unstructured":"Gonzalez-Duarte A, Cantu-Brito CG, Ruano-Calderon L, Garcia-Ramos G (2008) Clinical description of seizures in patients with systemic lupus erythematosus. Eur Neurol 59:320\u2013323","journal-title":"Eur Neurol"},{"key":"4891_CR47","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1212\/01.WNL.0000165959.98370.D5","volume":"64","author":"J Mikdashi","year":"2005","unstructured":"Mikdashi J, Krumholz A, Handwerger B (2005) Factors at diagnosis predict subsequent occurrence of seizures in systemic lupus erythematosus. Neurology 64:2102\u20132107","journal-title":"Neurology"},{"key":"4891_CR48","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/NMD.0000000000000946","volume":"207","author":"Y Lv","year":"2019","unstructured":"Lv Y, Zheng X, Zhang X, Zhao D, Cui L (2019) Tonic seizure as a different seizure type presented in autoimmune epilepsy caused by systemic lupus erythematosus. J Nerv Ment Dis 207:188\u2013191","journal-title":"J Nerv Ment Dis"},{"key":"4891_CR49","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s40744-020-00212-9","volume":"7","author":"F Basta","year":"2020","unstructured":"Basta F, Fasola F, Triantafyllias K, Schwarting A (2020) Systemic lupus erythematosus (SLE) therapy: the old and the new. Rheumatol Ther 7:433\u2013446","journal-title":"Rheumatol Ther"},{"key":"4891_CR50","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/gene.2010.73","volume":"12","author":"B Namjou","year":"2011","unstructured":"Namjou B, Kothari PH, Kelly JA, Glenn SB, Ojwang JO, Adler A, Alarc\u00f3nriquelme ME, Gallant CJ, Boackle SA, Criswell LA (2011) Evaluation of the TREX1 gene in a large multi-ancestral lupus cohort. Genes Immun 12:270\u2013279","journal-title":"Genes Immun"},{"key":"4891_CR51","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1528-1167.2007.01453.x","volume":"49","author":"JF Bautista","year":"2008","unstructured":"Bautista JF, Kelly JA, Harley JB, Gray-McGuire C (2008) Addressing genetic heterogeneity in complex disease: finding seizure genes in systemic lupus erythematosus. Epilepsia 49:527\u2013530","journal-title":"Epilepsia"},{"key":"4891_CR52","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1136\/ard.2010.130476","volume":"69","author":"GK Bertsias","year":"2010","unstructured":"Bertsias GK, Ioannidis JP, Aringer M, Bollen E, Bombardieri S, Bruce IN, Cervera R, Dalakas M, Doria A, Hanly JG, Huizinga TW, Isenberg D, Kallenberg C, Piette JC, Schneider M, Scolding N, Smolen J, Stara A, Tassiulas I, Tektonidou M, Tincani A, van Buchem MA, van Vollenhoven R, Ward M, Gordon C, Boumpas DT (2010) EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis 69:2074\u20132082","journal-title":"Ann Rheum Dis"},{"key":"4891_CR53","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/1471-2377-14-148","volume":"14","author":"E Ferlazzo","year":"2014","unstructured":"Ferlazzo E, Gambardella A, Bellavia M, Gasparini S, Mumoli L, Labate A, Cianci V, Russo C, Aguglia U (2014) Positivity to p-ANCA in patients with status epilepticus. BMC Neurol 14:148","journal-title":"BMC Neurol"},{"key":"4891_CR54","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.pediatrneurol.2010.03.014","volume":"43","author":"BM Moore","year":"2010","unstructured":"Moore BM, Rothman SM, Clark HB, Vehe RK, Laguna TA (2010) Epilepsy: an anticipatory presentation of pediatric Wegener's granulomatosis. Pediatr Neurol 43:49\u201352","journal-title":"Pediatr Neurol"},{"key":"4891_CR55","doi-asserted-by":"crossref","unstructured":"Pedrosa M, Drummond JB, Soares BS, Ribeiro-Oliveira A (2018)A combined outpatient and inpatient overnight water deprivation test is effective and safe in diagnosing patients with polyuria-polydipsia syndrome. Endocr Pract 24:963\u2013972","DOI":"10.4158\/EP-2018-0238"},{"key":"4891_CR56","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1111\/j.1471-4159.2007.05171.x","volume":"104","author":"DR Getts","year":"2008","unstructured":"Getts DR, Balcar VJ, Matsumoto I, Muller M, King NJ (2008) Viruses and the immune system: their roles in seizure cascade development. J Neurochem 104:1167\u20131176","journal-title":"J Neurochem"},{"key":"4891_CR57","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.2147\/NDT.S112145","volume":"12","author":"Y Lv","year":"2016","unstructured":"Lv Y, Wang Z, Chu F, Liu C, Meng H (2016) Epilepsia partialis continua present with shoulder joint-trunk-hip joint rhythmic clonic seizure: a case report. Neuropsychiatr Dis Treat 12:2363\u20132366","journal-title":"Neuropsychiatr Dis Treat"},{"key":"4891_CR58","first-page":"347","volume":"64","author":"T Solomon","year":"2012","unstructured":"Solomon T, Michael BD, Smith PE, Sanderson F, Davies NW, Hart IJ, Holland M, Easton A, Buckley C, Kneen R, National Encephalitis Guidelines Developement and Stakeholders Group (2012) Management of suspected viral encephalitis in adults\u2014Association of British Neurologists and British Infection Association National Guidelines. J Inf Secur 64:347\u2013373","journal-title":"J Inf Secur"},{"key":"4891_CR59","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1007\/s13365-017-0554-8","volume":"23","author":"MF Cusick","year":"2017","unstructured":"Cusick MF, Libbey JE, Doty DJ, Depaula-Silva AB, Fujinami RS (2017) The role of peripheral interleukin-6 in the development of acute seizures following virus encephalitis. J Neurovirol 23:696\u2013703","journal-title":"J Neurovirol"},{"key":"4891_CR60","doi-asserted-by":"crossref","unstructured":"Pandey S, Rathore C, Michael BD (2016) Antiepileptic drugs for the primary and secondary prevention of seizures in viral encephalitis. Cochrane Database Syst Rev:CD010247","DOI":"10.1002\/14651858.CD010247.pub3"},{"key":"4891_CR61","doi-asserted-by":"crossref","first-page":"e181","DOI":"10.1111\/j.1528-1167.2011.03289.x","volume":"52","author":"SH Nam","year":"2011","unstructured":"Nam SH, Lee BL, Lee CG, Yu HJ, Joo EY, Lee J, Lee M (2011) The role of ketogenic diet in the treatment of refractory status epilepticus. Epilepsia 52:e181\u2013e184","journal-title":"Epilepsia"},{"key":"4891_CR62","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3171\/jns.2000.92.2.0261","volume":"92","author":"B Bataille","year":"2000","unstructured":"Bataille B, Delwail V, Menet E, Vandermarcq P, Ingrand P, Wager M, Guy G, Lapierre F (2000) Primary intracerebral malignant lymphoma: report of 248 cases. J Neurosurg 92:261\u2013266","journal-title":"J Neurosurg"},{"key":"4891_CR63","doi-asserted-by":"crossref","first-page":"393","DOI":"10.4103\/1817-1745.174433","volume":"10","author":"V Suri","year":"2015","unstructured":"Suri V, Mittapalli V, Kulshrestha M, Premlani K, Sogani SK, Suri K (2015) Primary intraventricular central nervous system lymphoma in an immunocompetent patient. J Pediatr Neurosci 10:393\u2013395","journal-title":"J Pediatr Neurosci"},{"issue":"Suppl 1","key":"4891_CR64","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.1007\/s00247-010-1673-z","volume":"40","author":"MR Jordaan","year":"2010","unstructured":"Jordaan MR, Prabhu SP, Silvera VM (2010) Primary leptomeningeal central nervous system lymphoma in an immunocompetent adolescent: an unusual presentation. Pediatr Radiol 40(Suppl 1):S141\u2013S144","journal-title":"Pediatr Radiol"},{"key":"4891_CR65","first-page":"65","volume":"5","author":"H Farhangi","year":"2015","unstructured":"Farhangi H, Sharifi N, Ahanchian H, Izanloo A (2015) Autoimmune hemolytic anemia preceding the diagnosis of primary central nervous system lymphoma. Iran J Pediatr Hematol Oncol 5:65\u201369","journal-title":"Iran J Pediatr Hematol Oncol"},{"key":"4891_CR66","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jns.2019.03.011","volume":"400","author":"J Fox","year":"2019","unstructured":"Fox J, Ajinkya S, Houston P, Lindhorst S, Cachia D, Olar A, Kutluay E (2019) Seizures in patents with primary central nervous system lymphoma: prevalence and associated features. J Neurol Sci 400:34\u201338","journal-title":"J Neurol Sci"},{"key":"4891_CR67","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000495789","volume":"54","author":"A Biswas","year":"2019","unstructured":"Biswas A, Adhikari N, Bakhshi S, Gopinathan VR, Sharma MC (2019) A rare case of primary central nervous system lymphoma in an adolescent female treated with high-dose methotrexate and rituximab-based chemoimmunotherapy and consolidation whole brain radiotherapy. Pediatr Neurosurg 54:57\u201365","journal-title":"Pediatr Neurosurg"},{"key":"4891_CR68","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.neulet.2010.01.018","volume":"471","author":"JE Kim","year":"2010","unstructured":"Kim JE, Choi HC, Song HK, Jo SM, Kim DS, Choi SY, Kim YI, Kang TC (2010) Levetiracetam inhibits interleukin-1 beta inflammatory responses in the hippocampus and piriform cortex of epileptic rats. Neurosci Lett 471:94\u201399","journal-title":"Neurosci Lett"},{"key":"4891_CR69","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ana.21050","volume":"61","author":"J Dalmau","year":"2007","unstructured":"Dalmau J, Tuzun E, Wu HY, Masjuan J, Rossi JE, Voloschin A, Baehring JM, Shimazaki H, Koide R, King D, Mason W, Sansing LH, Dichter MA, Rosenfeld MR, Lynch DR (2007) Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 61:25\u201336","journal-title":"Ann Neurol"},{"key":"4891_CR70","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1684\/epd.2016.0797","volume":"18","author":"AM Khawaja","year":"2016","unstructured":"Khawaja AM, Vines BL, Miller DW, Szaflarski JP, Amara AW (2016) Refractory status epilepticus and glutamic acid decarboxylase antibodies in adults: presentation, treatment and outcomes. Epileptic Disord 18:34\u201343","journal-title":"Epileptic Disord"},{"key":"4891_CR71","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1212\/WNL.0000000000003536","volume":"88","author":"F Scheibe","year":"2017","unstructured":"Scheibe F, Pr\u00fcss H, Mengel AM, Kohler S, N\u00fcmann A, K\u00f6hnlein M, Ruprecht K, Alexander T, Hiepe F, Meisel A (2017) Bortezomib for treatment of therapy-refractory anti-NMDA receptor encephalitis. Neurology 88:366\u2013370","journal-title":"Neurology"},{"key":"4891_CR72","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jneuroim.2017.08.011","volume":"312","author":"O Sveinsson","year":"2017","unstructured":"Sveinsson O, Granqvist M, Forslin Y, Blennow K, Zetterberg H, Piehl F (2017) Successful combined targeting of B- and plasma cells in treatment refractory anti-NMDAR encephalitis. J Neuroimmunol 312:15\u201318","journal-title":"J Neuroimmunol"},{"key":"4891_CR73","doi-asserted-by":"crossref","first-page":"8903","DOI":"10.1158\/0008-5472.CAN-05-2726","volume":"66","author":"G Cimino","year":"2006","unstructured":"Cimino G, Lo-Coco F, Fenu S, Travaglini L, Finolezzi E, Mancini M, Nanni M, Careddu A, Fazi F, Padula F, Fiorini R, Spiriti MA, Petti MC, Venditti A, Amadori S, Mandelli F, Pelicci PG, Nervi C (2006) Sequential valproic acid\/all-trans retinoic acid treatment reprograms differentiation in refractory and high-risk acute myeloid leukemia. Cancer Res 66:8903\u20138911","journal-title":"Cancer Res"},{"key":"4891_CR74","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.pediatrneurol.2015.01.009","volume":"52","author":"K Moriyama","year":"2015","unstructured":"Moriyama K, Watanabe M, Yamada Y, Shiihara T (2015) Protein-losing enteropathy as a rare complication of the ketogenic diet. Pediatr Neurol 52:526\u2013528","journal-title":"Pediatr Neurol"},{"key":"4891_CR75","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10072-017-3158-4","volume":"39","author":"X Chen","year":"2018","unstructured":"Chen X, Xu G (2018) Intravenous thrombolysis in SLE-related stroke: a case report and literature review. Neurol Sci 39:155\u2013159","journal-title":"Neurol Sci"},{"key":"4891_CR76","doi-asserted-by":"crossref","first-page":"577144","DOI":"10.1016\/j.jneuroim.2020.577144","volume":"340","author":"R Uribe-San-Martin","year":"2020","unstructured":"Uribe-San-Martin R, Ciampi E, Cruz JP, Vasquez M, Carcamo C (2020) Refractory epilepsy associated with anti-ribosomal P antibodies successfully treated with topiramate. J Neuroimmunol 340:577144","journal-title":"J Neuroimmunol"},{"key":"4891_CR77","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1093\/tropej\/49.5.274","volume":"49","author":"PD Singhi","year":"2003","unstructured":"Singhi PD, Dinakaran J, Khandelwal N, Singhi SC (2003) One vs. two years of anti-epileptic therapy in children with single small enhancing CT lesions. J Trop Pediatr 49:274\u2013278","journal-title":"J Trop Pediatr"},{"key":"4891_CR78","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1469-8749.2011.03928.x","volume":"53","author":"P Singhi","year":"2011","unstructured":"Singhi P (2011) Infectious causes of seizures and epilepsy in the developing world. Dev Med Child Neurol 53:600\u2013609","journal-title":"Dev Med Child Neurol"},{"key":"4891_CR79","first-page":"95","volume":"2","author":"K Mokhtari","year":"2012","unstructured":"Mokhtari K, Houillier C, Hoangxuan K (2012) Brain biopsy in a patient suffering from primary CNS lymphoma treated with steroids. European Association of Neurooncology Magazine 2:95\u201396","journal-title":"European Association of Neurooncology Magazine"},{"key":"4891_CR80","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3389\/fpsyt.2017.00013","volume":"8","author":"A Al-Diwani","year":"2017","unstructured":"Al-Diwani A, Pollak TA, Langford AE, Lennox BR (2017) Synaptic and neuronal autoantibody-associated psychiatric syndromes: controversies and hypotheses. Front Psychiatry 8:13","journal-title":"Front Psychiatry"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-020-04891-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-020-04891-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-020-04891-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T11:39:26Z","timestamp":1611833966000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-020-04891-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,21]]},"references-count":80,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["4891"],"URL":"https:\/\/doi.org\/10.1007\/s10072-020-04891-8","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,21]]},"assertion":[{"value":"3 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}]}}